Gliomas, on the other hand, exhibit a biological response to Ex-4 through the GLP-1-R/Sirtuin 3 (SIRT3) signaling pathway, impeding proliferation, survival, and migration [20]. This evidence concerns the gene SIRT3 and central nervous system cancer.